CoreRX, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2006-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.corerxpharma.com
Starton Therapeutics Partners with Bend Bioscience to Develop Oral Sustained-Release Lenalidomide for Multiple Myeloma
Starton Therapeutics has entered a collaboration agreement with Bend Bioscience to develop STAR-LLD, an oral sustained-release formulation of lenalidomide designed to improve tolerability and efficacy in multiple myeloma treatment.